About CoLab Haus
Built by biotool builders.
CoLab Haus is run by people who build, sell, and ship lab products every day. We know what it takes to succeed because we're doing it ourselves.
CoLab Haus is run by people who build, sell, and ship lab products every day. We know what it takes to succeed because we're doing it ourselves.
CoLab Haus exists to give early-stage biotools founders the infrastructure, community, and operational support they need to build products that make science more accessible and affordable.
Most incubators chase therapeutics because that's where VC money flows. We serve the founders that VCs won't touch — the ones building the picks and shovels that make everyone else's science possible.
CoLab Haus isn't run by real estate developers or VC portfolio managers. It's run by people who manufacture PCR kits, ship extraction reagents, and sell lab supplies to hundreds of labs every week.
We know what it takes to get a biotools product from prototype to production because we do it ourselves. The infrastructure, the sales channels, the supply chain — it's all built from firsthand experience, not theory.
PCR kits · Extraction reagents · Lab supplies
CLIA-certified reference laboratory
Biotools incubator · Built for founders
David is the CEO of Filtrous, a clinical diagnostics company that manufactures PCR panels, extraction kits, and laboratory consumables. He's been building and selling biotools for years — and he built CoLab Haus because he saw the structural gap firsthand: talented scientists with viable biotools ideas, stuck because there's no infrastructure designed for them.
"Every major biotech hub has incubators for drug companies. Almost none have purpose-built infrastructure for the people building the tools, reagents, and instruments that make drug development possible. That's what CoLab Haus is."
— David Yazdi, Founder
Five reasons the biotools space is underserved — and what we're doing about it.
Thermo Fisher, Bio-Rad, Agilent control the market. Breaking in requires distribution infrastructure that startups don't have.
Too niche, too capital-light for VC return math. The fund model doesn't work for $5M exits — but those companies change science.
Existing lab space is expensive, designed for drug development, and located in the most expensive zip codes in the country.
Founders are brilliant scientists who need sales, distribution, and operational infrastructure — not just bench space.
12000 28th Street North, St. Petersburg, FL 33716. A 32,000 square foot purpose-built facility with easy access to Tampa Bay, USF, and the broader Florida life sciences corridor.
Florida has no state income tax, a lower cost of living than Boston or the Bay Area, and a growing biotech ecosystem. Your burn rate goes further here.
